Suppr超能文献

75 岁以上终末期肾病患者的健康相关生活质量和幸福感:英国和澳大利亚的一项横断面研究。

Health-related quality of life and well-being in people over 75 years of age with end-stage kidney disease managed with dialysis or comprehensive conservative care: a cross-sectional study in the UK and Australia.

机构信息

Health Economics, The University of Sydney, NHMRC Clinical Trials Centre, Sydney, New South Wales, Australia.

Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK.

出版信息

BMJ Open. 2019 May 19;9(5):e027776. doi: 10.1136/bmjopen-2018-027776.

Abstract

OBJECTIVE

To measure health-related quality of life (HRQoL) and well-being in older people with end-stage kidney disease (ESKD) and to determine the association between treatment type and sociodemographic characteristics on these outcome measures. In addition, to assess the convergent validity between the HRQoL and well-being measure and their feasibility and acceptability in this population.

DESIGN

Prospective cross-sectional study.

SETTING

Three renal units in the UK and Australia.

PARTICIPANTS

129 patients with ESKD managed with dialysis or with an estimated glomerular filtration ≤10 mL/min/1.73 m and managed with comprehensive conservative, non-dialytic care.

OUTCOME MEASURES

HRQoL and well-being were assessed using Short-Form six dimensions (SF-6D, 0-1 scale); Kidney Disease Quality of Life (KDQOL-36) (0-100 scale) and Investigating Choice Experiments Capability Measure-Older people (ICECAP-O, 0-1 scale). Linear regression assessed associations between treatment, HRQoL and well-being. Pearson's correlation coefficient assessed convergent validity between instruments.

RESULTS

Median age of 81 years (IQR 78-85), 65% males; 83 (64%) were managed with dialysis and 46 (36%) with conservative care. When adjusted for treatment type and sociodemographic variables, those managed on dialysis reported lower mean SF-6D utility (-0.05, 95% CI -0.12 to 0.01); lower KDQOL Physical Component Summary score (-3.17, 95% CI -7.61 to 1.27); lower Mental Component Summary score (-2.41, 95% CI -7.66 to 2.84); lower quality of life due to burden (-28.59, 95% CI -41.77 to -15.42); symptoms (-5.93, 95% CI -14.61 to 2.73) and effects of kidney disease (-16.49, 95% CI -25.98 to -6.99) and lower overall ICECAP-O well-being (-0.07, 95% CI -0.16 to 0.02) than those managed conservatively. Correlation between ICECAP-O well-being and SF-6D utility scores was strong overall, 0.65 (p<0.001), but weak to moderate at domain level.

CONCLUSIONS

Older people on dialysis report significantly higher burden and effects of kidney disease than those on conservative care. Lower HRQoL and well-being may be associated with dialysis treatment and should inform shared decision-making about treatment options.

TRIAL REGISTRATION NUMBER

UK (IRAS project ID: 134360andREC reference 14/LO/0291) and Australia (R20140203 HREC/14/RAH/36).

摘要

目的

测量终末期肾病(ESKD)老年人的健康相关生活质量(HRQoL)和幸福感,并确定治疗类型与社会人口统计学特征对这些结果的相关性。此外,评估 HRQoL 和幸福感测量之间的趋同效度以及在该人群中的可行性和可接受性。

设计

前瞻性横断面研究。

地点

英国和澳大利亚的三个肾脏单位。

参与者

129 名 ESKD 患者,接受透析治疗或估计肾小球滤过率≤10ml/min/1.73m,接受全面保守、非透析治疗。

主要观察指标

采用简短六维健康状况量表(SF-6D,0-1 量表)、肾脏病生活质量量表(KDQOL-36,0-100 量表)和调查选择实验能力量表-老年人(ICECAP-O,0-1 量表)评估 HRQoL 和幸福感。线性回归评估治疗、HRQoL 和幸福感之间的相关性。Pearson 相关系数评估工具之间的趋同效度。

结果

中位年龄 81 岁(IQR 78-85),65%为男性;83 例(64%)接受透析治疗,46 例(36%)接受保守治疗。调整治疗类型和社会人口统计学变量后,接受透析治疗的患者 SF-6D 效用评分较低(-0.05,95%CI -0.12 至 0.01);KDQOL 身体成分综合评分较低(-3.17,95%CI -7.61 至 1.27);心理成分综合评分较低(-2.41,95%CI -7.66 至 2.84);由于负担导致的生活质量较低(-28.59,95%CI -41.77 至 -15.42);症状(-5.93,95%CI -14.61 至 2.73)和肾脏疾病的影响(-16.49,95%CI -25.98 至 -6.99);整体 ICECAP-O 幸福感较低(-0.07,95%CI -0.16 至 0.02)。与保守治疗相比,接受透析治疗的患者报告的负担和肾脏疾病的影响明显更高。较低的 HRQoL 和幸福感可能与透析治疗有关,并应告知关于治疗选择的共同决策。

试验注册

英国(IRAS 项目 ID:134360 和 REC 参考 14/LO/0291)和澳大利亚(R20140203 HREC/14/RAH/36)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab3/6530299/35138b419dc0/bmjopen-2018-027776f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验